BIG
DFTX

Brooklyn Investment Group’s Definium Therapeutics DFTX Stock Holding History

Brooklyn Investment Group’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-519
Closed -$3.37K – 1909
2025
Q2 		$3.37K Buy
519
+137
+36% +$901 ﹤0.01% 2617
2025
Q1 		$2.23K Buy
+382
New +$2.74K ﹤0.01% 2129

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Brooklyn Investment Group's DFTX Position: Q3 2025 in Review

Brooklyn Investment Group sold out of Definium Therapeutics (DFTX) in Q3 2025, closing a stake of 519 shares — an estimated $3.37K sold.

Brooklyn Investment Group first reported a position in DFTX in Q1 2025 and held it in 2 quarters. The position peaked at $3.37K in Q2 2025. 195 funds tracked by Wall St. Rank hold DFTX as of Q3 2025.

  • Brooklyn Investment Group reported no remaining Definium Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Brooklyn Investment Group sold 519 Definium Therapeutics shares in Q3 2025, an estimated $3.37K.
  • Brooklyn Investment Group first reported a position in Definium Therapeutics in Q1 2025 and held it in 2 quarters.
  • Brooklyn Investment Group's Definium Therapeutics position peaked at $3.37K in Q2 2025.
  • 195 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2025.

Based on Brooklyn Investment Group's 13F filing for Q3 2025, filed 14 Nov 2025.